HOME >> BIOLOGY >> NEWS
Candidate Regulator Of The Temporal Component Of Neurotransmitter Release Identified

In a joint effort, the groups of Heinrich Betz from the Max Planck Institute for Brain Research (Frankfurt, Germany) and George Augustine from the Duke University (Durham, NC) have tested the hypothesis that NSF, a ubiquitous protein required for a variety of general membrane fusion and secretion events in eukaryotic cells, is also involved in neurotransmitter release at synapses. Their results, appearing in the February 20 issue of SCIENCE, provide the first hints at molecular events that may control the time course of neurotransmitter release.

Nerve cells release neurotransmitter by allowing transmitter containing organelles, so called synaptic vesicles, to fuse with the neuronal plasma membrane, thus secreting their content. This process has recently been found to share many similarities with general vesicle trafficking events, e.g. protein transport to the cell surface, as employed by cells from yeast to mammals. The major differences are speed - synaptic vesicles can perform secretion within 200 microseconds after arrival of a stimulus - and tight control by calcium levels, which must rise thousandfold to trigger vesicle fusion. Using a combination of molecular biological and physiological techniques, the groups of Betz and Augustine now have found evidence that the speed of transmitter release itself may be controlled, somewhat ironically, by the evolutionarily highly conserved general fusion protein NSF (for N-methylmaleimide sensitive fusion protein). The groups have synthesized NSF-fragments and screened these peptides for their potency to prevent the major activator of NSF, the soluble NSF-attachment protein SNAP, from interacting with NSF in vitro. To elucidate the consequences of perturbed NSF-function for an intact synapse, inhibitory peptides were then injected into the nerve termin
'"/>

Contact: George Augustine
georgea@neuro.duke.edu
919-681-6165
Max-Planck-Gesellschaft
20-Feb-1998


Page: 1 2

Related biology news :

1. AAAS US Presidential Candidates Forum
2. US Presidential Candidates Forum
3. Tigecycline - Candidate antibiotic produces 74 percent cure rate in cSSSI patients
4. Candidate genes found which may play a role in cancer progressing from non-invasive to invasive
5. UCSD And NIH Researchers Isolate Candidates For Genetic Basis Of Human Taste
6. New Tuberculosis Vaccine Candidate Developed: Improved Delivery Of Antigens By Current Vaccine BCG (Bacille Calmette-Gurin)
7. Duke Researchers Discover Candidate Susceptibility Gene For Autoimmune Disease
8. Researchers, Regulators, Industry, Consumer Advocates Gather to Discuss Critical Issues Facing the Pharmaceutical Industry
9. New Insights Into The Transport Machinery Of The Cell: A Single Protein Substitutes The Regulatory Machinery Specifying Endosome Fusion In Vitro
10. Neurons Control Brain Immunity: Neurotrophins As Regulators Of Antigen-Presentation In Microglial Cells
11. Regulator Of Fat Thermostat Found

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... , ... July 09, 2020 , ... Today CJ BIO ... which will share insight on the “fifth taste” phenomenon that is revolutionizing ingredient mixes, ... Umami Advantage will be live on Monday, July 13, 2020 at11:00 AM (CDT) during ...
(Date:7/1/2020)... ... July 01, 2020 , ... Catalent, a ... purchase of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in the Shiga prefecture ... facility located in Kakegawa, the new 60,000-square-foot facility will provide customers with flexible ...
(Date:6/25/2020)... ... June 24, 2020 , ... eClinical Solutions LLC , ... that accelerate drug development, is collaborating with Karyopharm Therapeutics (Nasdaq: KPTI ) ... with severe COVID-19. This is the first study of an XPO1 inhibitor in ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... July 09, 2020 , ... In ... commonly used to suppress pigment formation in zebrafish embryos, maintaining optical transparency to ... by Dr MA has been using the zebrafish model to investigate the causes ...
(Date:7/7/2020)... ... July 06, 2020 , ... Bio-IT World ... Eli Lilly, Bristol-Myers Squibb, the University of Chicago, Massachusetts General Hospital, Mission: Cure, ... an elite awards program, highlighting outstanding examples of how technology innovations and strategic ...
(Date:7/1/2020)... ... June 30, 2020 , ... ... the launch of a new clinical diagnostics immuno-oncology service, TissueInsight . ... (TME). , “Flagship’s TissueInsight is a service that aids pathologists, oncologists, and ...
(Date:6/28/2020)... ... June 25, 2020 , ... Lumeda Inc. ... cancer, today announced the company has entered a license agreement with Roswell Park ... Lumeda globally exclusive rights to Roswell Park intellectual property surrounding a novel medical ...
Breaking Biology Technology:
Cached News: